Catalpol Alleviates Depression by Inhibiting NLRP3 Inflammasome via TLR4/MAPK/NF-Kb Pathway.

导出 OA

翻译打印收藏纠错

作者： Xuemei,Liang ^[1] ; Yuhuan,Zhao ^[2] ; Tianjiao,Xu ^[3] ; Wei,Wang ^[4] ; Weidong,Sun ^[1] ; Rui,Wang ^[3]

作者单位： The Fourth Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China. ^[1] The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China. ^[2] Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, 161000, China. ^[3] Mudanjiang Medical College, Mudanjiang 155000, China. ^[4]

关键词 Depression Inflammasome Therapy

DOI 10.18502/ijph.v52i4.12440

PMID 37551177

发布时间 2023-08-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Iranian journal of public health

2023年52卷4期

722-731页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Catalpol Alleviates Depression by Inhibiting NLRP3 Inflammasome via TLR4/MAPK/NF-Kb Pathway.

Iranian journal of public health

相似文献

Iranian journal of public health

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Catalpol Alleviates Depression by Inhibiting NLRP3 Inflammasome via TLR4/MAPK/NF-Kb Pathway.

Iranian journal of public health

相似文献

Iranian journal of public health

相关期刊

检索历史清除